The numerous advances in the understanding of the neurobiology of Alzheimers disease in the past 15 years have suggested many new potential targets for therapeutic intervention. This article gives a broad overview of the spectrum of targets for AD treatment, with particular emphasis on amyloid β-peptides and tau protein.
Keywords: Alzheimers Disease, Amyloid Plaques, Tau Phosphorylation Inhibitors, Tau Aggregation Blockers, GLIAL CELLS
open access plus
Rights & PermissionsPrintExport